Welcome to the Keypoint Newsletter, bringing you all the latest news & views from Keystone Symposia!
Featuring conference season highlights, spotlights on innovation and more, this biannual publication showcases Keystone Symposia’s efforts-- past, present & future-- to catalyze collaborative partnerships and inspire innovation in science and medicine around the world.
We are delighted to announce our new President and Chief Executive Officer, Dr. James (Jamie) Baumgartner! Jamie brings to the organization more than 20 years of experience in biotechnology and pharmaceutical sectors, including academic and other partnerships. He has a strong scientific background in various therapeutic areas and a noteworthy reputation as a leader and a strategic thinker, with considerable business development and financial experience. ...Read More
Featuring messages from Dr. Jamie Baumgartner, Dr. Walter Moos (Chair of the Board of Directors & Search Committee) and Dr. Debbie Johnson (outgoing CEO).
Keystone Symposia’s flagship Fellows Program is now accepting applications for the Class of 2025! This unique, cutting-edge, life science Fellowship is designed to support the career development of postdoctoral and early-career scientists in biological or biomedical sciences research. Current and alumni Fellows serve as leaders in their communities. Here we highlight recent news and accomplishments. ...Read More
As climate change increasingly impacts society and human health around the globe, the world is in need of science-based solutions to mitigate the growing crisis. Keystone Symposia is assembling field leaders in sustainability science and climate medicine to collectively address current challenges and chart a path forward to a healthier planet and healthier communities in these three upcoming conferences in 2025. ...Read More
Climate change has quickly become one of the greatest threats we have ever faced as a society, and we are uniquely poised to bring together the scientific community to collectively address this vast problem.
Last year we launched a new 2-day format for conferences on emerging topics, which were met with great enthusiasm by the nascent communities of scientists exploring these new frontiers of research. This year we have planned five exciting 2-day meetings on topics ranging from interoception to microproteins, where the science and clinical implications are rapidly expanding. ...Read More
Our new job board is designed to connect job seekers with leading employers in academia & bioscience industries, creating a nexus where scientific talent thrives. The KS Career Center offers a variety of tools to connect with the best candidates, whether you are looking for your next post-doc or the newest member of your industry team.
Keystone Symposia is only as strong as the community that supports us. The engagement of the community is essential to fulfill our mission. Sponsors and donors allow us to provide mission-driven initiatives that truly make an impact on science, and the scientists we serve. ...Read More
In June we wrapped up our 2024 conference season, aligning with the academic calendar. Altogether we hosted 52 conferences across North America, Europe and Asia, serving nearly 9,000 participants and providing financial aid to over 500 students, post-docs, and scientists from around the world. Find out more about our attendees below and see what they are saying about Keystone Symposia!...Read More
Find out how to submit your idea for consideration by our Scientific Advisory Board HERE We will begin selecting our 2027 portfolio of meetings this fall!
Find out more about the meeting selection and planning process HERE
Shannon Weiman earned her PhD in Biomedical Sciences from the University of California, San Diego, specializing in microbiology and immunology. Prior to joining the Keystone Symposia team, she worked as a freelance writer for leaders in academic, industry and government research, including Stanford University’s Biomedical Innovation Initiative, the University of Colorado’s Biofrontiers Program, UCSF, the FDA and the American Society for Microbiology.